Benefit assessment in Germany: Implications for price discounts
Year of publication: |
2016
|
---|---|
Authors: | Theidel, Ulrike ; von der Schulenburg, Johann-Matthias Graf |
Published in: |
Health Economics Review. - Heidelberg : Springer, ISSN 2191-1991. - Vol. 6.2016, 33, p. 1-12
|
Publisher: |
Heidelberg : Springer |
Subject: | Health policy | Pharmaceuticals | Market access | Rebate | Negotiation | New substance |
-
Benefit assessment in Germany : implications for price discounts
Theidel, Ulrike, (2016)
-
Who is Best at Negotiating Pharmaceutical Rebates?
Abrams, Lawrence W., (2011)
-
Who is Best at Negotiating Pharmaceutical Rebates?
Abrams, Lawrence, (2016)
- More ...
-
Benefit assessment in Germany : implications for price discounts
Theidel, Ulrike, (2016)
-
Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
Kuhlmann, Alexander, (2012)
-
Theidel, Ulrike, (2017)
- More ...